bFGF-polymer conjugates, methods for making the same and applications thereof

Patent metadata

Field	Value
Publication number	US-10039807-B2
Application number	US-201715427918-A
Country	US
Kind code	B2
Filing date	Feb 8, 2017
Priority date	Nov 28, 2011
Publication date	Aug 7, 2018
Grant date	Aug 7, 2018

Abstract

A heparin mimicking polymer, its conjugate with bFGF, and method of making and using the same are disclosed. In particular, described herein are conjugates of biologic agents (e.g., bFGF) and heparin mimicking polymers having superior stability while retaining full native activity after a variety of stressors.

First claim

We claim:

1. A heparin mimicking polymer, comprising the combination of a polymer and a reactive group;
wherein said polymer is selected from the group consisting of selected from the group consisting of poly(styrene sulfonate) (pSS), poly(styrene sulfonate)-co-poly(polyethylene glycol methacrylate) (pSS-co-PEGMA), poly(sodium vinyl sulfonic acid) (pVS), and a combination thereof;
wherein the reactive group reacts with a moiety in a target protein causing a covalent attachment of the heparin mimicking polymer to the target protein, wherein the reactive group is capable of reacting with the moiety in the target protein selected from the group consisting of a free thiol group, an amine group, an aldehyde group, a carboxyl group, a hydroxyl group, a ketone group, an oxo group, an azide group, an alkyne group, and a combination there,
wherein the reactive group is selected from the group consisting of activated disulfides, pyridyl disulfide, 5-thio-2-nitrobenzoic acid, disulfide reductants, Michael acceptors, maleimides, maleimide derivatives, dihalomaleimides, vinyl groups, vinyl sulfones, acryloyl derivatives, haloacetvh alkyl halide derivatives, aziridines, arylating agents, isothiocyanates, isocyanates, acryl azides, activated esters, N-hydroxysuccinimide esters, para-nitrophenyl esters, sulfonyl chlorides, aldehydes and glyoxals (with or without reductive animation), epoxides (also called oxiranes), carbonates, arylating agents, imidoesters, carbodiimides, anhydrides, primary amines, secondary amines, tertiary amines, diazoalkanes, diazoacetyls, carbonyldiimidazoles, carbonates, chloroformates, alkyl halogens, isocyanates, aminooxy (hydroxylamines), hydrazines, alkynes, derivatives thereof, and a combination thereof.

2. The heparin mimicking polymer of claim 1 , wherein the reactive group is activated disulfide, pyridyl disulfide, 5-thio-2-nitrobenzoic acid, or disulfide reductant, which is capable of reacting with the moiety in the target protein which is present naturally in the target protein or added by chemical or biological modification.

3. The heparin mimicking polymer of claim 1 , having the general structure: —[R 1 R 2 C—CR 3 R 4 ] n —, wherein R1-R4 are selected from the group consisting of a hydrogen, an alkyl, an aryl, an alkene, an alkyne, and any derivative thereof.

4. The heparin mimicking polymer of claim 3 , wherein one of the R 1 -R 4 groups comprises a negatively charged moiety.

5. The heparin mimicking polymer of claim 4 , wherein the negatively charged moiety is selected from the group consisting of a sulfate, a sulfonate, a carboxylate, and a combination thereof.

6. The heparin mimicking polymer of claim 1 , wherein the reactive group is Michael acceptors, maleimides, maleimide derivatives, dihalomaleimides, vinyl groups, vinyl sulfones, acryloyl derivatives, haloacetyl, alkyl halide derivatives, aziridines, arylating agents, isothiocyanates, isocyanates, acryl azides, activated esters, N-hydroxysuccinimide esters, para-nitrophenyl esters, sulfonyl chlorides, aldehydes and glyoxals (with or without reductive amination), epoxides (also called oxiranes), carbonates, arylating agents, imidoesters, carbodiimides, anhydrides, primary amines, secondary amines, tertiary amines, diazoalkanes, diazoacetyls, carbonyldiimidazoles, carbonates, chloroformates, alkyl halogens, isocyanates, aminooxy (hydroxylamines), hydrazines, alkynes, derivatives thereof, or a combination thereof, which is capable of reacting with the moiety in the target protein which is present naturally in the target protein or added by chemical or biological modification.

Assignees

• Univ California

Inventors

• Maynard Heather D
• Nguyen Thi

Classifications

• C08F212/30

  Sulfur · CPC title

• A61P17/00

  Drugs for dermatological disorders · CPC title

• A61K47/32

  Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone} · CPC title

• A61K31/795

  Polymers containing sulfur · CPC title

• A61K31/78

  of acrylic acid or derivatives thereof · CPC title